AstraZeneca

Evusheld has Emergency Use Authorisation (EUA) for pre-exposure prophylaxis (prevention) of COVID-19

Neutralising anti-body levels against Omicron following a third-dose boost of Vaxzevria were broadly similar to levels achieved…

The news comes days after Reuters reported that tens of millions of migrants may be denied COVID-19 vaccines from the…

According to WHO, Covovax was assessed under its emergency use listing procedure based on the review of data on quality, safety…

Only antibody authorised in the US for pre-exposure prophylaxis of COVID-19

AstraZeneca is currently the most distributed vaccine by COVAX, according to data from Gavi, the vaccine alliance that co-manages…

Researchers from the University of Oxford published results yesterday from a study yet to be peer-reviewed, where they analysed…

Phase-III data showed at least six months of protection with one dose in high-risk participant population

Argentina was one of the first countries to widely use Russia's Sputnik V COVID-19 vaccine, but delays in deliveries led the…

The study found that six out of the seven boosters examined enhanced immunity after initial vaccination with Pfizer-BioNTech's…